Client News Bone Biologics readies for large animal studiesBone Biologics is on the brink of completing an important milestone in its mission to develop the NELL-1 osteoinductive protein… Read Full Story
Client News Bone Biologics announces $5.75M funding for bone graft substitute development projectBone Biologics has just announced the completion of a $5.75 funding venture in collaboration with Musculoskeletal Transplant Foundation, OrthoFix Holdings,… Read Full Story